Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Nuvalent

Biotech & Life Sciences · Cambridge, United States · Founded 2017 · IPO 2021 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation
$6.45B
Market cap · Apr/2026

Investors

12 investors on Nuvalent's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 1 investor entered at this stage
Deerfield
Series B+ 11 investors entered at this stage
Wellington Management
Viking Global Investors
Fairmount Funds Management
Boxer Capital
Fidelity Investments
Driehaus Capital Management
Logos Capital
Janus Henderson Investors
Venrock
Avoro Capital Advisors
Bain Capital Life Sciences

Global footprint

Where Nuvalent has talent and traffic

Web traffic by country
28K monthly visits
across markets
🇺🇸 United States91.8%
🇨🇦 Canada4.3%
🇮🇳 India3.6%
Top 3 markets shown

See Nuvalent on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo